Why the study?
Does implantable cardioverter-defibrillator shock acutely impair cardiac function and hemodynamics in patients with reduced versus preserved left ventricular ejection fraction?
Does implantable cardioverter-defibrillator shock acutely impair cardiac function and hemodynamics in patients with reduced versus preserved left ventricular ejection fraction?
ICD shocks cause transient impairment of cardiac function and hemodynamics, particularly in patients with pre-existing systolic dysfunction, without causing significant myocardial tissue injury.
Answers are grounded in this paper and cite their sources.
May warrant transient monitoring post-DFT in reduced-EF patients; hypothesis-generating for ICD shock effects on function.
Background— We investigated the acute effects of implantable cardioverter-defibrillator shock on myocardium, cardiac function, and hemodynamics in relation to left ventricular systolic function. Methods and Results— We studied 50 patients who underwent implantable cardioverter-defibrillator implantation and defibrillation threshold (DFT) testing: 25 patients with left ventricular ejection fraction (LVEF) ≥45% and 25 patients with LVEF <45%. We measured cardiac biomarkers (creatine kinase, creatine kinase-MB, myoglobin, cardiac troponin T and I, and N-terminal probrain natriuretic peptide). Left ventricular relaxation was assessed by global longitudinal strain rate during the isovolumetric relaxation period using speckle-tracking echocardiography. Blood sampling and echocardiography were performed before, immediately after, and 5 minutes and 4 hours after DFT testing. Mean arterial pressure was measured directly during DFT testing. Cardiac biomarkers showed no significant changes in either group. LVEF was decreased until 5 minutes after DFT testing and had recovered to the baseline at 4 hours in the group with reduced LVEF ( P <0.001), whereas LVEF reduction was not observed in the group with preserved LVEF ( P =0.637). Global isovolumetric relaxation period was decreased until 5 minutes after DFT testing and had recovered to the baseline at 4 hours in both groups (preserved LVEF: 0.39±0.14 versus 0.23±0.13* versus 0.23±0.13* versus 0.40±0.13 s −1 , * P <0.001 versus baseline; reduced LVEF: 0.15±0.05 versus 0.08±0.04† versus 0.09±0.04† versus 0.15±0.05 s −1 , † P <0.001 versus baseline, repeated-measures ANOVA). Time to recovery of mean arterial pressure to the baseline was prolonged in the group with reduced LVEF ( P <0.001). Conclusions— Implantable cardioverter-defibrillator shock transiently impairs cardiac function and hemodynamics especially in patients with systolic dysfunction, although significant tissue injury is not observed.
No takes yet. Share an insight, caveat, or question.
Toh et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: